Nathaniel Wang

Nathaniel Wang

Company: Replicate Bioscience

Job title: Chief Executive Officer & Co-Founder


Next Generation Self-Replicating RNA Vectors to Enable New Approaches to Immunotherapy 9:30 am

Next generation synthetic srRNA vectors can lower dose by orders of magnitude compared to current srRNA designs Developing new srRNA products requires independent optimization of vectors, gene inserts, and delivery Improved srRNA bioactivity enable new approaches for immunotherapies in oncologyRead more

day: Day Two

Breakfast Panel: What does the Future Landscape of Next Generation RNA Therapeutics Look Like? 9:00 am - 9:30 am

• What are considered as next generation RNA therapeutics and where is innovation expected to come from? • Lessons learned from the first ever approved/authorized mRNA-based vaccine • Upcoming challenges for the next wave of mRNA-based vaccine and next generation RNA therapeutics • New technologies for further improvements of mRNA therapeutics to achieve proof of…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.